Patents by Inventor Allan C. Shaw

Allan C. Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIC-1 fusion proteins and uses thereof
    Patent number: 9956264
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: May 1, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Allan C. Shaw, Charlotte Helgstrand, Michael P. Bastner Sandrini, Sebastian B. Joergensen, Henning Thoegersen, Kristian Sass-Oerum, Sven Hastrup, Kim V. Andersen
  • MIC-1 FUSION PROTEINS AND USES THEREOF
    Publication number: 20160129083
    Abstract: The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analogue thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
    Type: Application
    Filed: January 19, 2016
    Publication date: May 12, 2016
    Inventors: Allan C. Shaw, Charlotte Helgstrand, Michael P. Bastner Sandrini, Sebastian B. Joergensen, Henning Thoegersen, Kristian Sass-Oerum, Sven Hastrup, Kim V. Andersen
  • Peptidyl ?-hydroxyglycine ?-amidating lyases
    Patent number: 9096843
    Abstract: The present patent application concerns an enzyme capable of catalysing the conversion of a ?-hydroxyglycine to an ?-amide and the use of such enzymes for producing a C-terminal ?-amidated peptide.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: August 4, 2015
    Assignee: Novo Nordisk A/S
    Inventor: Allan C. Shaw
  • NOVEL PEPTIDYL ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASES
    Publication number: 20120322733
    Abstract: The present patent application concerns an enzyme capable of catalysing the conversion of a ?-hydroxyglycine to an ?-amide and the use of such enzymes for producing a C-terminal ?-amidated peptide.
    Type: Application
    Filed: December 1, 2010
    Publication date: December 20, 2012
    Applicant: Novo Nordisk A/S
    Inventor: Allan C. Shaw